New Arthritis Drug Prevents Joint Damage

Friday, 22 Nov 2013 12:27 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink

A potential rheumatoid arthritis treatment from French drugmaker Sanofi and its U.S. development partner Regeneron Pharmaceuticals Inc. fared better than a fake drug at improving disease signs and symptoms in a late-stage study.
 
The companies said Friday they saw a statistically significant improvement in patient groups that received their drug, sarilumab, combined with methotrexate compared to those who just received methotrexate and a placebo.
 
About 1,200 patients enrolled in the study. Researchers tested two doses of the drug in adults with active rheumatoid arthritis who were not helped by methotrexate.

Editor's note: 3 Signs You’re Close to a Heart Attack
 
Aside from improving signs and symptoms, the treatment also helped physical function and inhibited joint damage progression, the companies said.
 
Rheumatoid arthritis is a chronic inflammatory disease that affects the joints and destroys soft tissue, cartilage and bone. It represents a major area of research for drug companies because it is chronic, meaning patients will likely take the drugs regularly for a long time.
 
Last year, the Food and Drug Administration approved a new treatment for the disease, Pfizer Inc.'s twice-a-day pill Xeljanz.
 

© Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Civilian Life, Not Combat, Drives Many Vets to Drink: Study

Thursday, 31 Jul 2014 17:32 PM

Difficulties in civilian life, rather than war experiences, are a source of drinking problems among U.S. National Guard  . . .

Medicare Drug Premiums to Rise for Second Year in a Row

Thursday, 31 Jul 2014 17:26 PM

Medicare says premiums for prescription drug plans will rise in 2015 for the second year in a row.
Officials said  . . .

Ebola Crisis Grows: What You Need to Know

Thursday, 31 Jul 2014 16:55 PM

Schools have closed, there are house-to-house searches for the sick, and the death toll continues to rise from the Ebola . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved